Report Finds List Prices for Best-Selling Medicare Part D Prescription Drugs… Read More
Big Pharma Hides Behind False Innovation Rhetoric to Maintain Rampant Abuse of… Read More
Analysis Details How Big Pharma’s Patent Abuse Delays Generic and Biosimilar… Read More
Pfizer CEO Highlights Delayed Competition on Blockbuster Drug as Reason to Be… Read More
AbbVie CEO Touts Patent Abuse to Extend Exclusivity on Blockbuster Skyrizi,… Read More
Sanofi Touts Patent Thickets, Legal Strategy to Block Competition to Dupixent… Read More
Analysis Demonstrates Tremendous Cost of Anti-Competitive Tactics Like Patent… Read More
Johnson & Johnson Beats Profit Expectations, Lifts Forecast Following… Read More
Big Pharma Giants Acquire New Blockbuster Products with Existing History of… Read More
Bipartisan Letter Targets Big Pharma’s Misleading Ads That Inflate Costs And… Read More
Administration Touts Positive Steps to Bring More Biosimilars to Market… Read More
New Report Details Impact of Big Pharma Giant’s Strategy to Maintain… Read More